Gilead Sciences, Inc. (NEO:GILD)
25.31
+0.98 (4.03%)
Oct 17, 2025, 4:00 PM EDT
Gilead Sciences Revenue
Gilead Sciences had revenue of $7.08 billion USD in the quarter ending June 30, 2025, with 1.84% growth. This brings the company's revenue in the last twelve months to $28.86 billion, up 3.81% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75 billion with 6.04% growth.
Revenue (ttm)
$28.86B
Revenue Growth
+3.81%
P/S Ratio
5.44
Revenue / Employee
$1.64M
Employees
17,600
Market Cap
214.13B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
dentalcorp Holdings | 1.62B |
Trulieve Cannabis | 1.62B |
Green Thumb Industries | 1.57B |
Extendicare | 1.51B |
Verano Holdings | 1.16B |
WELL Health Technologies | 1.12B |
Sienna Senior Living | 929.68M |